{"id":3018,"date":"2018-03-07T12:03:57","date_gmt":"2018-03-07T12:03:57","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/technical-note\/cytochrome-p450-inhibition-reversible\/"},"modified":"2018-03-07T12:03:57","modified_gmt":"2018-03-07T12:03:57","slug":"cytochrome-p450-inhibition-reversible","status":"publish","type":"technical-note","link":"https:\/\/www.sygnaturediscovery.com\/fr\/technical-note\/cytochrome-p450-inhibition-reversible\/","title":{"rendered":"P450 \/ CYP Inhibition"},"content":{"rendered":"<p>Inhibition of cytochrome P450 (CYP450) enzymes is one of the major reasons for drug-drug interactions (DDI), as they play a significant role in the metabolism of both endogenous and exogenous compounds.<\/p>\n<p>Therefore, detailed CYP inhibition profiles are now required for the registration of novel molecular entities. Using either liver microsomes or recombinant CYP preparations like Bactosomes, in combination with specific probe substrates, we can assess inhibition of individual CYPs by your discovery compounds. As a reliable and cost-effective initial screening we recommend assessing inhibition potencies against the 5 most relevant CYP isoforms, i.e. CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 using\u00a0Cypex\u00a0Bactosomes. The measurement of the inhibition of each of these CYP450 enzymes in human liver microsomes (HLM) helps in predicting the potential for drug-drug interactions with co-administered drugs and in understanding the subsequent clinical consequences. Please see\u00a0<a href=\"http:\/\/dmd.aspetjournals.org\/content\/31\/7\/955.long\">Weaver R. et al., 2003, DMD 31:7, p. 955-966<\/a>\u00a0for reference.<\/p>\n<p>By introducing a 30 minute pre-incubation in the absence or presence of NADPH, we can distinguish between direct, time-dependent, and metabolism-dependent inhibition. Our inhibition assays are generally performed using seven concentrations covering four orders of magnitude. Please feel free to inquire about more detailed investigations, e.g. Ki\/KI determination.<\/p>\n<h2><strong><em>Direct inhibition<\/em><\/strong><\/h2>\n<p>Direct inhibition, sometimes referred to as reversible inhibition, is the most basic form of enzyme inhibition. It is assessed by measurement of an enzyme activity in the presence of increasing concentration of inhibitor without a pre-incubation step. This is the classic\u00a0<em>in vitro<\/em>\u00a0inhibition assay which, if positive, yields an\u00a0IC<sub>50<\/sub>-value as a result.<\/p>\n<p>Sygnature\u2019s Standard Reversible <a href=\"https:\/\/www.sygnaturediscovery.com\/publications\/technical-notes\/cytochrome-p450-inhibition-time-dependent-ic50-shift\/\">CYP450<\/a> Inhibition assay utilises drug-like probe substrates, HLM and the Phase I cofactor, NADPH.\u00a0The assay monitors for the formation of the metabolites of the drug-like probe substrates in the absence and presence of a compound by LC-MS\/MS. All assays have two replicates per compound and include a positive control inhibitor. Data output consists of the generation of an inhibition constant or IC<sub>50<\/sub>\u00a0value.<\/p>\n<p>To discuss the availability of other CYP isoform inhibition assays, <a href=\"https:\/\/www.sygnaturediscovery.com\/contact\/\">contact us<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Discover P450\/CYP inhibition &#038; drug interactions. Assess CYP isoforms, predict co-administered drug risks. Reliable screening with Sygnature.<\/p>\n","protected":false},"featured_media":0,"template":"","category":[1],"resource_tag":[],"class_list":["post-3018","technical-note","type-technical-note","status-publish","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>P450 \/ CYP Inhibition - Sygnature<\/title>\n<meta name=\"description\" content=\"Discover P450\/CYP inhibition &amp; drug interactions. Assess CYP isoforms, predict co-administered drug risks. Reliable screening with Sygnature.\" \/>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"P450 \/ CYP Inhibition - Sygnature\" \/>\n<meta property=\"og:description\" content=\"Discover P450\/CYP inhibition &amp; drug interactions. Assess CYP isoforms, predict co-administered drug risks. Reliable screening with Sygnature.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/technical-note\/cytochrome-p450-inhibition-reversible\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/sygnature-hit-to-lead-team-collaboration-scaled.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/technical-note\\\/cytochrome-p450-inhibition-reversible\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/technical-note\\\/cytochrome-p450-inhibition-reversible\\\/\",\"name\":\"P450 \\\/ CYP Inhibition - Sygnature\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"datePublished\":\"2018-03-07T12:03:57+00:00\",\"description\":\"Discover P450\\\/CYP inhibition & drug interactions. Assess CYP isoforms, predict co-administered drug risks. Reliable screening with Sygnature.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/technical-note\\\/cytochrome-p450-inhibition-reversible\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/technical-note\\\/cytochrome-p450-inhibition-reversible\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/technical-note\\\/cytochrome-p450-inhibition-reversible\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/page-daccueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"P450 \\\/ CYP Inhibition\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature Discovery\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature Discovery\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"P450 \/ CYP Inhibition - Sygnature","description":"Discover P450\/CYP inhibition & drug interactions. Assess CYP isoforms, predict co-administered drug risks. Reliable screening with Sygnature.","robots":{"index":"noindex","follow":"follow"},"og_locale":"fr_CA","og_type":"article","og_title":"P450 \/ CYP Inhibition - Sygnature","og_description":"Discover P450\/CYP inhibition & drug interactions. Assess CYP isoforms, predict co-administered drug risks. Reliable screening with Sygnature.","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/technical-note\/cytochrome-p450-inhibition-reversible\/","og_site_name":"Sygnature","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/sygnature-hit-to-lead-team-collaboration-scaled.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/technical-note\/cytochrome-p450-inhibition-reversible\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/technical-note\/cytochrome-p450-inhibition-reversible\/","name":"P450 \/ CYP Inhibition - Sygnature","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"datePublished":"2018-03-07T12:03:57+00:00","description":"Discover P450\/CYP inhibition & drug interactions. Assess CYP isoforms, predict co-administered drug risks. Reliable screening with Sygnature.","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/technical-note\/cytochrome-p450-inhibition-reversible\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/technical-note\/cytochrome-p450-inhibition-reversible\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/technical-note\/cytochrome-p450-inhibition-reversible\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"P450 \/ CYP Inhibition"}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature Discovery","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature Discovery"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/technical-note\/3018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/technical-note"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/technical-note"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/technical-note\/3018\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=3018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=3018"},{"taxonomy":"resource_tag","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/resource_tag?post=3018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}